transcripts whereas the decrease of the 2 kb and 1. 0- 1. 5 kb IGF-I mRNA variety was lesser. Densitometric In the kidneys, no significant alterations were detectable after intramuscular injection of TO (Fig. 2B together with E). In lung, modest and large intestine, only trace numbers of IGF-I mRNA were detectable (info not shown). 3. 2. Serum IGF-I concentrations all through TO-induced acute-phase reaction To check whether the decrease involving hepatic IGF-I mRNA expression in the TO model resulted with reduced circulating IGF-I concentrations, serum concentrations of entire IGF-I were measured by the rat IGF-I specific radioimmunoassay. These experiments demonstrated a reliable decline of serum IGF-I all through TO-induced APR with low levels at 12 they would after TO injection (Fig. 3). At this time point, serum IGF-I concentrations of TO-treated rats were approximately 50% of the from control rats Phrase of IGF-I mRNA in rat liver, kidney together with spleen during acute-phase reaction induced by turpentine oil injection. Total RNA (10 lg) from liver (A, Debbie), kidney (B, E) and spleen (J, F) at several time points after TO injection were hybridized with [32P]-labeled cDNA specific for rat IGF-I. (Debbie, E, F) Densitometric test of bands corresponding on the 7. 5 kb, several kb, 2 kb together with 1. 0-1. 5 kb IGF-I mRNA in liver (D), kidney (Orite) and spleen (Farrenheit). The relative densities associated with bands were expressed as the percentage of decrease compared with the respective IGF-I mRNA stage at 0 h (n = 4, means ± SD). Statistically serious differences are indicated (*p < 0. 01, **p < 0. 001 for individual values compared with the IGF-I mRNA level at 0 h just by ANOVA, post-test Newmann-Keuls examination). Serum IGF-I concentrations during acute-phase response stimulated by turpentine oil injection in rats. injected with saline. Nevertheless, 36 h after TO HELP injection, serum concentrations of IGF-I returned to the levels of control wildlife (Fig. 3). In charge rats injected with saline, no significant alterations with the serum IGF-I concentrations were observed. 3. 3. Temporal and spatial IGFBP-1 mRNA expression during TO-induced acute-phase reaction Northern blot analysis involving total RNA isolated with liver and kidney revealed an individual 1. 5 kb mRNA transcript specific for rat IGFBP-1. TO-induced APR was accompanied by elevation of IGFBP-1 gene phrase in both organs in a time-dependent manner (Fig. 4A and B). The amount of IGFBP-1 transcripts in that liver started to increase already 30 min after TO injection, and their own maximal levels were arrived at at 6 h. Densitometric analysis revealed that IGFBP-1 mRNA levels of TO-treated rats at now point were 410 ± 40% involving levels observed than in the respective control animals (Fig. 4A). Unlike the liver, the elevation of IGFBP-1 mRNA expression inside kidneys was delayed and less prominent. In comprehensive RNA from kidney, the amount of IGFBP-1 transcripts started to increase 2 h after TO injection reaching maximum levels at 12 h, when IGFBP-1 mRNA with TO-treated rats were 170 ± 10% of levels of untreated controls (Fig. melanotan-i, research peptides bodybuilding, gnrh antagonist
1. 5 kb IGF-I mRNA variety was lesser. Densitometric
In the kidneys, no significant alterations
were detectable after intramuscular injection of
TO (Fig. 2B together with E). In lung, modest and large intestine,
only trace numbers of IGF-I mRNA were detectable
(info not shown).
3. 2. Serum IGF-I concentrations all through TO-induced
acute-phase reaction
To check whether the decrease involving hepatic IGF-I
mRNA expression in the TO model resulted with reduced
circulating IGF-I concentrations, serum concentrations of entire
IGF-I were measured by the rat IGF-I specific radioimmunoassay.
These experiments demonstrated a reliable
decline of serum IGF-I all through TO-induced APR with
low levels at 12 they would after TO injection (Fig. 3). At this
time point, serum IGF-I concentrations of TO-treated
rats were approximately 50% of the from control rats
Phrase of IGF-I mRNA in rat liver, kidney together with spleen during acute-phase reaction induced by turpentine oil injection. Total RNA
(10 lg) from liver (A, Debbie), kidney (B, E) and spleen (J, F) at several time points after TO injection were hybridized with [32P]-labeled cDNA specific
for rat IGF-I. (Debbie, E, F) Densitometric test of bands corresponding on the 7. 5 kb, several kb, 2 kb together with 1. 0-1. 5 kb IGF-I mRNA in liver (D), kidney (Orite)
and spleen (Farrenheit). The relative densities associated with bands were expressed as the percentage of decrease compared with the respective IGF-I mRNA stage at 0 h
(n = 4, means ± SD). Statistically serious differences are indicated (*p < 0. 01, **p < 0. 001 for individual values compared with the IGF-I mRNA
level at 0 h just by ANOVA, post-test Newmann-Keuls examination).
Serum IGF-I concentrations during acute-phase response
stimulated by turpentine oil injection in rats. injected with saline. Nevertheless, 36 h after TO HELP injection,
serum concentrations of IGF-I returned to the levels
of control wildlife (Fig. 3). In charge rats injected with
saline, no significant alterations with the serum IGF-I concentrations
were observed.
3. 3. Temporal and spatial IGFBP-1 mRNA expression
during TO-induced acute-phase reaction
Northern blot analysis involving total RNA isolated with
liver and kidney revealed an individual 1. 5 kb mRNA transcript
specific for rat IGFBP-1. TO-induced APR was
accompanied by elevation of IGFBP-1 gene phrase
in both organs in a time-dependent manner (Fig. 4A
and B). The amount of IGFBP-1 transcripts in that liver
started to increase already 30 min after TO injection,
and their own maximal levels were arrived at at 6 h. Densitometric
analysis revealed that IGFBP-1 mRNA levels of
TO-treated rats at now point were 410 ± 40% involving
levels observed than in the respective control animals
(Fig. 4A). Unlike the liver, the elevation of
IGFBP-1 mRNA expression inside kidneys was
delayed and less prominent. In comprehensive RNA from kidney,
the amount of IGFBP-1 transcripts started to
increase 2 h after TO injection reaching maximum levels
at 12 h, when IGFBP-1 mRNA with TO-treated rats were
170 ± 10% of levels of untreated controls (Fig. melanotan-i, research peptides bodybuilding, gnrh antagonist